Ocuphire Pharma Inc (OCUP)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Mina P. Sooch
Employees:
9
37000 GRAND RIVER AVE., SUITE 120, FARMINGTON HILLS, MI, 48335
248-681-9815
Date | Ratio |
---|---|
2005-05-16 | 1:1 |
2017-05-05 | 1:10 |
2019-04-12 | 1:12 |
2020-11-06 | 1:4 |
Ocuphire Pharma, Inc. focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, which is in Phase III clinical trial for dim light or night vision disturbances. The company also develops APX3330, a twice-a-day oral tablet to target pathways relevant to retinal and choroidal vascular diseases.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|